OXURION to Participate in the 10th edition of Degroof Petercam’s Healthcare Conference
Leuven, BELGIUM, Boston, MA, US – January 18, 2022 – 08.00 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will participate in the 10th edition of Degroof Petercam's Healthcare Conference:
10th edition of Degroof Petercam's Healthcare Conference
January 24-28, 2022
1x1 and small group investor meetings only
For more information, please visit Oxurion's events page.